Vertex Pharmaceuticals Inc.

URI: https://gptkb.org/entity/Vertex_Pharmaceuticals_Inc.
GPTKB entity
Statements (32)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:acquiredBy gptkb:Semma_Therapeutics
gptkb:ViaCyte
gptkbp:CEO gptkb:Reshma_Kewalramani
gptkbp:collaboratesWith gptkb:Moderna
gptkb:CRISPR_Therapeutics
gptkbp:country gptkb:United_States
gptkbp:focusArea sickle cell disease
beta thalassemia
cystic fibrosis
gptkbp:foundedIn 1989
gptkbp:founder gptkb:Joshua_Boger
gptkbp:headquartersLocation gptkb:Boston,_Massachusetts,_United_States
https://www.w3.org/2000/01/rdf-schema#label Vertex Pharmaceuticals Inc.
gptkbp:industry gptkb:biotechnology
gptkbp:marketCap over $100 billion (2024)
gptkbp:netIncome $3.6 billion (2023)
gptkbp:notableProduct gptkb:Kalydeco
gptkb:Orkambi
gptkb:Symdeko
gptkb:Trikafta
gptkbp:numberOfEmployees 2023
~4,500
gptkbp:publiclyTraded true
gptkbp:researchArea gene editing
small molecule drugs
gptkbp:revenue $8.93 billion (2023)
gptkbp:stockExchange gptkb:NASDAQ
gptkbp:stockSymbol gptkb:VRTX
gptkbp:website https://www.vrtx.com/
gptkbp:bfsParent gptkb:^NDX
gptkbp:bfsLayer 6